<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115890">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01777568</url>
  </required_header>
  <id_info>
    <org_study_id>12-891</org_study_id>
    <nct_id>NCT01777568</nct_id>
  </id_info>
  <brief_title>Supplemental Oxygen in Colorectal Surgery: A Quality Improvement Project</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our primary objective is to develop a clinical pathway for care of patients having
      colorectal surgery at the Clinic. In particular, the investigators would like to determine
      what intraoperative concentration of oxygen is optimal in our patients. The investigators
      therefore propose to test the primary hypothesis that supplemental oxygen (80% versus 30%)
      reduces the risk of a composite of surgical sites infection and potentially oxygen-related
      wound complications. Secondarily, the investigators will assess the incremental cost benefit
      of 80% versus 30% oxygen. As a safety measure, enough oxygen will always be given to
      maintain oxygen saturation (as determined by pulse oximetry) ≥95%.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>determining optimal intraoperative oxygen concentration</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Our primary objective is to develop a clinical pathway for care of patients having colo-rectal surgery at the Clinic. In particular, we would like to determine what intraoperative concentration of supplemental oxygen (30% or 80%)is optimal in our patients. As a safety measure, enough oxygen will always be given to maintain oxygen saturation (as determined by pulse oximetry) ≥95%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cost benefit analysis for oxygen concentration</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Secondarily, we will assess the incremental cost benefit of 80% versus 30% oxygen</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">5017</enrollment>
  <condition>Oxygen Concentration During Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>30 % oxygen</arm_group_label>
    <description>Operating room will be maintained at 30% oxygenation during colorectal surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>80 % oxygen</arm_group_label>
    <description>Operating room will be maintained at 80% oxygenation during colorectal surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>30% oxgen</intervention_name>
    <description>Operating room will be maintained at 30% oxygenation during colorectal surgery.</description>
    <arm_group_label>30 % oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>80% oxygen</intervention_name>
    <description>Operating room will be maintained at 80% oxygenation.</description>
    <arm_group_label>80 % oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult colorectal surgical patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult colorectal surgical patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Kurz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveand Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Kurz, MD</last_name>
    <phone>216-445-9924</phone>
    <email>ak@or.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gretchen Upton</last_name>
    <phone>216-905-3932</phone>
    <email>uptong@ccf.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Kurz, MD</last_name>
      <phone>216-444-9924</phone>
      <email>ak@or.org</email>
    </contact>
    <contact_backup>
      <last_name>Gretchen Upton</last_name>
      <phone>216-905-3932</phone>
      <email>uptong@ccf.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 28, 2013</lastchanged_date>
  <firstreceived_date>December 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Andrea Kurz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
